The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It's free.
Data released Aug. 13 by the Centers for Disease Control and Prevention (CDC) showed that between Dec. 14, 2020 and Aug. 6, 2021, a total of 571,831 total adverse events were reported to VAERS, including 12,791 deaths — an increase of 425 over the previous week. There were 77,490 reports of serious injuries, including deaths, during the same time period — up 7,385 compared with the previous week.
Excluding “foreign reports” filed in VAERS, 451,049 adverse events, including 5,859 deaths and 36,871 serious injuries, were reported in the U.S. Of the 5,859 U.S. deaths reported as of Aug. 6, 13% occurred within 24 hours of vaccination, 19% occurred within 48 hours of vaccination and 33% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 349.8 million COVID vaccine doses had been administered as of Aug. 6. This includes: 140 million doses of Moderna’s vaccine, 196 million doses of Pfizer and 13 million doses of the Johnson & Johnson (J&J) COVID vaccine.
The data comes directly from reports submitted to the Vaccine Adverse Event Reporting System (VAERS), the primary government-funded system for reporting adverse vaccine reactions in the U.S.
Every Friday, VAERS makes public all vaccine injury reports received as of a specified date, usually about a week prior to the release date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
This week’s U.S. data for 12- to 17-year-olds show:
- 16,408 total adverse events, including 983 rated as serious and 18 reported deaths. Two of the eighteen deaths were suicides.
The most recent reported deaths include a 15-year-old boy (VAERS I.D. 1498080) who previously had COVID, was diagnosed with cardiomyopathy in May 2021 and died four days after receiving his second dose of Pfizer’s vaccine on June 18, when he collapsed on the soccer field and went into ventricular tachycardia; and a 13-year-old girl (VAERS I.D. 1505250) who died after suffering a heart condition after receiving her first dose of Pfizer.
- Other deaths include two 13-year-old boys (VAERS I.D. 1406840 and 1431289) who died two days after receiving a Pfizer vaccine, a 13-year-old boy who died after receiving Moderna (VAERS I.D. 1463061), three 15-year-olds (VAERS I.D. 1187918, 1382906 and 1242573), five 16-year-olds (VAERS I.D. 1420630, 1466009, 1225942, 1475434, and 1386841) and three 17-year-olds (VAERS I.D. 1199455, 1388042 and 1420762).
- 2,424 reports of anaphylaxis among 12- to 17-year-olds with 99% of cases
attributed to Pfizer’s vaccine.
- 419 reports of myocarditis and pericarditis (heart inflammation) with 414 cases attributed to Pfizer’s vaccine.
- 81 reports of blood clotting disorders, with all cases attributed to Pfizer.
This week’s total U.S. VAERS data, from Dec. 14, 2020 to Aug. 6, 2021, for all age groups combined, show:
- 21% of deaths were related to cardiac disorders.
- 54% of those who died were male, 43% were female and the remaining death reports did not include gender of the deceased.
- The average age of death was 73.1.
- As of Aug 6., 2,695 pregnant women reported adverse events related to COVID vaccines, including 931 reports of miscarriage or premature birth.
- Of the 2,585 cases of Bell’s Palsy reported, 50% were attributed to Pfizer vaccinations, 43% to Moderna and 6% to J&J.
- 510 reports of Guillain-Barré Syndrome, with 40% of cases attributed to Pfizer, 34% to Moderna and 25% to J&J.
- 123,496 reports of anaphylaxis with 45% of cases attributed to Pfizer’s vaccine, 47% to Moderna and 8% to J&J.
- 8,218 reports of blood clotting disorders. Of those, 3,428 reports were attributed to Pfizer, 3,510 reports to Moderna and 1,695 reports to J&J.
- 2,076 cases of myocarditis and pericarditis with 1,309 cases attributed to Pfizer, 690 cases to Moderna and 71 cases to J&J’s COVID vaccine.
FDA authorizes extra vaccine doses for immunocompromised patients
As The Defender reported Aug. 13, neither vaccine has yet received full FDA approval, and neither has completed late-stage clinical trials proving a third dose will boost immunity or work against COVID variants.
The FDA’s amended Emergency Use Authorization allows people who have had an organ transplant, or those with a similar level of weakened immune system, to get an extra COVID vaccine dose. The J&J vaccine was not included because there was not sufficient data on boosters, according to the agency.
The FDA’s decision “allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from COVID19,” Dr. Janet Woodcock, FDA acting commissioner, tweeted Aug. 12.
“Others who are fully vaccinated are adequately protected & do not need an additional dose of COVID-19 vaccine at this time,” Woodcock tweeted.
The vulnerable group of patients make up less than 3% of U.S. adults, according to CDC Director Dr. Rochelle Walensky.
Heart inflammation after COVID vaccines more common than CDC claims, new research shows U.S. public health officials claim cases of myocarditis and pericarditis following COVID vaccination are rare — but new research published online in the Journal of American Medical Association (JAMA) shows they may happen more often than reported.
Post-vaccine myocarditis and pericarditis also appear to represent two “distinct syndromes,” Dr. George Diaz, with the Providence Regional Medical Center Everett, told Medscape Cardiology.
Diaz and colleagues reviewed 2,000,287 electronic medical records (EMR) of people who received at least one COVID vaccination. The records, obtained from 40 hospitals in Washington, Oregon, Montana and California, showed 20 people had vaccine-related myocarditis (1.0 per 100,000) and 37 had pericarditis (1.8 per 100,000).
The new JAMA study showed a “similar pattern [to the CDC study], although at higher incidence [of myocarditis and pericarditis] after vaccination, suggesting vaccine adverse event under-reporting.”
The JAMA report also stated: “Additionally, pericarditis may be more common than myocarditis among older patients.”
“Our study resulted in higher numbers of cases probably because we searched the EMR, and [also because] VAERS requires doctors to report suspected cases voluntarily,” Diaz told Medscape.
The researchers calculated the average monthly number of cases of myocarditis or pericarditis during the pre-vaccine period of January 2019 through January 2021 was 16.9 compared with 27.3 during the vaccine period of February through May 2021. The mean numbers of pericarditis cases during the same periods were 49.1 and 78.8.
The authors said limitations of their analysis include potential missed cases outside care settings and missed diagnoses of myocarditis or pericarditis, which would underestimate the incidence, as well as inaccurate EMR vaccination information.
Mom of 14-year-old who developed myocarditis after Pfizer vaccine no longer trusts public health officials
In an exclusive interview last week with The Defender, Emily Jo said before her son, Aiden, got his first dose of Pfizer’s vaccine, she was led to believe his chance of suffering an adverse reaction was “one in a million.”
Aiden, a 14-year-old from Georgia, had no history of COVID or pre-existing conditions, except for asthma. On June 10, several days after his second Pfizer shot, Aiden woke his mother up at 4:30 a.m. because his chest hurt and he couldn’t breathe.
Jo said she was aware of the potential side effect of heart inflammation, but she believed the CDC, which said the reaction was very rare and mild. “What they didn’t explain is that mild means hospital care and follow-up care indefinitely,” Jo said.
“The biggest problem is they [CDC] are not explaining what mild myocarditis means,” Jo said. “Aiden’s cardiologist told us no case of myocarditis is ‘mild.’ That’s like saying a heart attack is mild,” she said the cardiologist told her.
Jo said her son tires easily and his recovery will be a long process. She said all her kids are fully vaccinated and she was one of the most trusting advocates of the CDC and American Academy of Pediatrics — until her son experienced his vaccine injury.
Another sad story! Mom so proud that her 14-year-old son could get the COVID vaccine… but now doctors confirm her son meets the criteria for having post-vaccine myocarditis.
— Robert F. Kennedy Jr (@RobertKennedyJr) August 11, 2021
25-year-old develops myocarditis after Moderna vaccine
In another exclusive interview last week with The Defender, Deborah Brenner said her son, a healthy 25-year-old from Ohio, experienced myocarditis five days after his first dose of Moderna’s COVID vaccine, administered on July 22.
Christopher Brenner developed a fever after the vaccine, and within five days, he was experiencing chest pain so intense he was unable to sleep, so he went to the Defiance Mercy Clinic.
When Christopher was in the ER, tests showed his troponin levels were high. “I was alarmed at that point,” Brenner said.
“One of the ER nurses mentioned it could be myocarditis from the vaccine, but everyone else played it down like it was serious — but wasn’t a big deal,” Brenner said. “When his numbers jumped higher, that’s when it became more serious.”
When nurses took Christopher’s troponin level a second time it was higher, so they kept him overnight.
“When he was still in Defiance, we saw the internist who diagnosed my son with myocarditis and said it was a reaction to the vaccine,” Brenner said. “The internist explained that one type of inflammation is around the heart and one is inside the heart — and Christopher’s was the type that caused inflammation inside the heart.”
Christopher’s troponin level continued to rise, so he was transferred by ambulance to St. Vincent Hospital in Toledo. Benner said the cardiologists in Toledo were totally against connecting the reaction to the vaccine. “They didn’t want to go there, didn’t want to talk about it and just said his numbers would come back down,” she said. “I was getting really frustrated because I was wondering what was going on in his heart that we couldn’t see.”
After four days of being hospitalized and treated with blood thinners and beta blockers, Christopher was discharged. The discharge doctor told Brenner he didn’t know why the other physicians didn’t want to admit her son’s reaction was caused by the vaccine.
“Everybody has allergic reactions and your son just had an allergic reaction to the vaccine,” he said. “I can’t sit here and tell you 100% that the vaccine is the cause but the fact that he got the vaccine and days later started having issues — something was going on.”
EU looking into new possible side-effects of mRNA COVID Vaccines
The European Medicines Agency’s (EMA) safety committee is studying erythema multiforme, a form of allergic skin reaction; glomerulonephritis, or kidney inflammation; and nephrotic syndrome, a renal disorder characterized by heavy urinary protein losses, Reuters reported.
The EMA did not give details on how many cases of the new conditions were recorded, but said it had requested more data from the vaccine makers.
The regulator, which disclosed the new assessments as part of routine updates to the safety section of authorized vaccines’ database, did not recommend changes to the labels of mRNA vaccines at this time.
Pfizer’s efficacy plummets to 42% as Delta variant takes hold
As The Defender reported Aug. 11, a new preprint study showed mRNA vaccines’ effectiveness plummeted in July when Delta variant was dominant — with Moderna only 76% effective and Pfizer only 42% effective against infection.
A new preprint study showed mRNA vaccines’ effectiveness plummeted in July when Delta variant was dominant — with Moderna only 76% effective and Pfizer only 42% effective against infection.
— Robert F. Kennedy Jr (@RobertKennedyJr) August 12, 2021
The study, which raised concerns about the effectiveness of mRNA COVID vaccines — particularly Pfizer’s — against the Delta variant, caught the attention of top Biden administration officials, Axios reported.
“If that’s not a wake up call, I don’t know what is,” a senior Biden official told Axios.
The study, which has yet to be peer-reviewed, compared the effectiveness of Moderna and Pfizer COVID vaccines in the Mayo Clinic Health System from January to July 2021, during which time either the Alpha or Delta variant were highly prevalent.
Overall, researchers found Moderna’s vaccine was 86% effective against infection over the study period, and Pfizer’s was 76% effective. Moderna’s vaccine was 92% effective against hospitalization and Pfizer’s was 85% effective. There were no deaths in either cohort.
But vaccine efficacy dropped sharply in July, when the Delta variant was more prevalent. Moderna was only 76% effective against infection and Pfizer was only 42% effective.
“We observed a pronounced reduction in the effectiveness of BNT162b2 [Pfizer] coinciding with the surging prevalence of the Delta variant in the United States, but this temporal association does not imply causality,” Venky Soundararajan and his co-authors wrote.
The authors concluded “further evaluation of mechanisms underlying differences in their effectiveness such as dosing regimens and vaccine composition are warranted.”
158 days and counting, CDC ignores The Defender’s inquiries
According to the CDC website, “the CDC follows up on any report of death to request additional information and learn more about what occurred and to determine whether the death was a result of the vaccine or unrelated.”
On March 8, The Defender contacted the CDC with a written list of questions about reported deaths and injuries related to COVID vaccines. We have made repeated attempts, by phone and email, to obtain a response to our questions.
Despite multiple phone and email communications with many people at the CDC, and despite being told that our request was in the system and that someone would respond, we have not yet received answers to any of the questions we submitted. It has been 158 days since we sent our first email to the CDC requesting information.